CENTOGENE Reports First Half 2023 Financial Results
Strong Revenues and Steady Growth in Both Diagnostics and Pharma Segments Drive Sustainable Financial Performance…
News
Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases
TOKYO and SEATTLE, Sept. 07, 2023 (GLOBE NEWSWIRE) — Otsuka Pharmaceutical Co., Ltd. (Otsuka) and…
Lumos Pharma Announces Participation in Investor Conferences in September
AUSTIN, Texas, Sept. 07, 2023 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company…
IMUNON to Host Virtual R&D Day on September 14th Beginning at 4:00 p.m. ET
Program will feature members of IMUNON executive management along with key opinion leaders in immuno-oncology…
Lexicon Pharmaceuticals to Participate in the H.C. Wainwright & Co. 25th Annual Global Investment Conference
THE WOODLANDS, Texas, Sept. 07, 2023 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today…
Celularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to its Board of Directors
Pharmaceutical and Academic Veteran Brings Significant Innovative Technology and Development Expertise Launching New Cellular Therapies…
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023
— Recorded First Quarter Revenue of $37.7 Million — — Signed $36 Million in Net…
Codexis Announces Agreement for Assignment and Assumption of San Carlos Facility Lease
Assignment results in estimated cumulative cash savings of more than $30M and supports projected cash runway…
4DMT to Participate in Upcoming Investor Conferences
EMERYVILLE, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT, 4DMT),…
T2 Biosystems to Participate in the Gilmartin Group Emerging Growth Company Showcase
LEXINGTON, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen
BELTSVILLE, Md., Sept. 07, 2023 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company…
Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies
– Two preclinical studies of RaniPill® HC achieved 18/20 successful drug delivery of orally administered…
Aruna Bio Announces Preclinical Results from Pilot Study Evaluating AB126 for the Treatment of Amyotrophic Lateral Sclerosis
– Data from superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS) mouse model demonstrated prolonged…
Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference
WESTLAKE VILLAGE, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late…
Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
MONT-SAINT-GUIBERT, Belgium, Sept. 07, 2023 (GLOBE NEWSWIRE) — Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology”…
Intermap Enables World Class Space Infrastructure with New 3D Data Exploitation Contract
First award from the leading private commercial spacecraft/launch/communications customer, supporting its LEO satellites Endorsement of…
Royal York Property Management Receives Official Accreditations From Canadian Financial Institutions
Royal York Property Management Listed on Canadian Bill Pay System Toronto, Ontario–(Newsfile Corp. – September…
Dunamis Charge to Showcase EV Chargers and CEO Natalie King’s Electrification Insights at NAIAS 2023
Clean energy thought leader Natalie King to join State of Michigan Office of Future Mobility…
KBRA Assigns Preliminary Ratings to Morgan Stanley Residential Mortgage Loan Trust 2023-INV1 (MSRM 2023-INV1)
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to 24 classes of mortgage pass-through certificates from Morgan…
BEN, A Provider of Personalized Customer Engagement AI Technology, to Go Public on Nasdaq Through Proposed Business Combination with DHC Acquisition Corp.
BEN’s advanced and engaging consumer AI interfaces support clients whose priority is to dramatically improve…